series-c-plus
Stage
1
Investors
About
ArmaGen Technologies develops engineered biologic medicines that enhance the half-life and tissue targeting of therapeutics through novel antibody engineering and drug delivery platforms.
Explore ArmaGen Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.